Back | Next |
home / stock / ptgx / ptgx message board
Subject | By | Source | When |
---|---|---|---|
I agree. pullback was to be expected. | rib eye | investorshub | 10/12/2021 8:42:36 PM |
Had hoped that this would continue to move | ok2buy | investorshub | 10/12/2021 8:32:44 PM |
Volume has tapered off, but still getting ugly. | rib eye | investorshub | 10/12/2021 5:15:46 PM |
Buckle up. Believe this will move back up./ok2 | ok2buy | investorshub | 10/12/2021 1:51:11 PM |
Shake the tree now. Institutions looking to | ok2buy | investorshub | 10/12/2021 1:47:35 PM |
A couple new price targets posted minutes ago, | ok2buy | investorshub | 10/12/2021 1:29:49 PM |
$PTGX Chart | conix | investorshub | 10/11/2021 9:07:15 PM |
znewcar1: PTGX 93% v45,5M c35.36 f47,5M gapNchop H37.1+S32.3 | znewcar1 | investorshangout | 10/11/2021 8:04:47 PM |
36.55 | crudeoil24 | investorshub | 10/11/2021 4:47:07 PM |
Out at $35 | ErnieBilco | investorshub | 10/11/2021 3:05:44 PM |
Buckle up. I believe we retest this | ok2buy | investorshub | 10/11/2021 1:49:49 PM |
The FDA lifted the hold, this could easily | ok2buy | investorshub | 10/11/2021 1:29:17 PM |
Setting up to break through $20.00./ok2 | ok2buy | investorshub | 10/08/2021 2:17:15 PM |
I'm not the on to ask about $PTGX, sorry... | dealerschool2006 | investorshub | 10/07/2021 3:04:13 PM |
Any thoughts on where this is going to go? | Peach_Tree | investorshub | 10/07/2021 2:34:53 PM |
Company asked to present at the AASLD Liver | ok2buy | investorshub | 10/07/2021 2:34:31 PM |
I like to scan for panic sales like | dealerschool2006 | investorshub | 09/27/2021 6:18:35 PM |
For investors, the following information: | ok2buy | investorshub | 09/25/2021 4:21:00 PM |
Just watched a large order get filled @ | ok2buy | investorshub | 09/23/2021 1:43:26 PM |
The company is cooperating with the FDA. | ok2buy | investorshub | 09/23/2021 12:44:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Protagonist Therapeutics Inc. Company Name:
PTGX Stock Symbol:
NASDAQ Market:
Protagonist Therapeutics Inc. Website:
Dr. Yeilding joins Protagonist from Janssen Pharmaceutical Companies of Johnson & Johnson, where he held leadership roles in the immunology therapeutic area, bringing extensive experience in R&D and commercialization of novel therapeutics in the I&I space NEWARK, CA / ACCESSWIRE /...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 75.8% to $0.0457 on volume of 1,196,767,473 shares NVIDIA Corporation (NVDA) fell 6.8% to $114.25 on volume of 316,196,296 shares Sangamo Therapeutics Inc. (SGMO) rose 39.5% to $0.56 on volume of 261...
NEWARK, CA / ACCESSWIRE / July 22, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and one-on-one meetings at the BTIG Virtual Biotechnolog...